Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase II Trial of Single Fraction Radiation Therapy (SFRT) at Roswell Park Cancer Institute for Select Patients With Early Stage Breast Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01754519
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:30.710326+00:00
Published At
2017-06-06T00:00:00+00:00
Record Updated At
2017-07-07
Results Posted At
2017-06-06
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Ductal Breast Carcinoma In Situ", "Estrogen Receptor Negative", "Estrogen Receptor Positive", "HER2/Neu Negative", "Invasive Cribriform Breast Carcinoma", "Invasive Ductal Carcinoma, Not Otherwise Specified", "Lobular Breast Carcinoma In Situ", "Mucinous Breast Carcinoma", "Papillary Breast Carcinoma", "Progesterone Receptor Positive", "Stage I Breast Cancer", "Stage II Breast Cancer", "Stage IIIA Breast Cancer", "Stage IIIC Breast Cancer", "Tubular Breast Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2017-07-07"
protocolSection.identificationModule.nctId
"NCT01754519"
protocolSection.identificationModule.officialTitle
"Phase II Trial of Single Fraction Radiation Therapy (SFRT) at Roswell Park Cancer Institute for Select Patients With Early Stage Breast Cancer"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2017-06-06"

Study condition terms

  • Ductal Breast Carcinoma In Situ (protocolSection.conditionsModule.conditions)
  • Estrogen Receptor Negative (protocolSection.conditionsModule.conditions)
  • Estrogen Receptor Positive (protocolSection.conditionsModule.conditions)
  • HER2/Neu Negative (protocolSection.conditionsModule.conditions)
  • Invasive Cribriform Breast Carcinoma (protocolSection.conditionsModule.conditions)
  • Invasive Ductal Carcinoma, Not Otherwise Specified (protocolSection.conditionsModule.conditions)
  • Lobular Breast Carcinoma In Situ (protocolSection.conditionsModule.conditions)
  • Mucinous Breast Carcinoma (protocolSection.conditionsModule.conditions)
  • Papillary Breast Carcinoma (protocolSection.conditionsModule.conditions)
  • Progesterone Receptor Positive (protocolSection.conditionsModule.conditions)
  • Stage I Breast Cancer (protocolSection.conditionsModule.conditions)
  • Stage II Breast Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIA Breast Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIC Breast Cancer (protocolSection.conditionsModule.conditions)
  • Tubular Breast Carcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.